La biopsie du ganglion sentinelle dans les cancers de l’endomètre est-elle faisable ?

[1]  F. Narducci,et al.  Complications des lymphadénectomies cœlioscopiques en oncologie gynécologique : 1102 interventions chez 915 patientes , 2005 .

[2]  Z. Holub,et al.  Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[3]  N. Yaegashi,et al.  Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. , 2004, Gynecologic oncology.

[4]  K. Kerrou,et al.  Technique du ganglion sentinelle appliquée aux cancers de l’utérus : étude préliminaire , 2004 .

[5]  Serge Uzan,et al.  Laparoscopic Sentinel Node Procedure Using a Combination of Patent Blue and Radiocolloid in Women With Endometrial Cancer , 2004, Annals of Surgical Oncology.

[6]  M. J. Webb,et al.  Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. , 2003, Gynecologic oncology.

[7]  F. Armellino,et al.  Sentinel Lymph Node (SLN) laparoscopic assessment early stage in endometrial cancer. , 2003, Minerva ginecologica.

[8]  G. Bisi,et al.  Preliminary Study of Sentinel Node Identification with 99mTc Colloid and Blue Dye in Patients with Endometrial Cancer , 2002, Tumori.

[9]  M. J. Webb,et al.  Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. , 2001, Gynecologic oncology.

[10]  M. Kawai,et al.  Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. , 2001, Gynecologic oncology.

[11]  P. V. van Diest,et al.  Pathological investigation of sentinel lymph nodes , 1999, European Journal of Nuclear Medicine.

[12]  H. Hollema,et al.  Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  K. Benediktsdottir,et al.  Survival and prognostic factors of endometrial cancer patients in Iceland 1964–1985: Can attendance at population‐based pap‐smear screening affect survival? , 1998, International journal of cancer.

[14]  N. Sakuragi,et al.  A clinical and pathologic study on para‐aortic lymph node metastasis in endometrial carcinoma , 1997, Journal of surgical oncology.

[15]  J. Wharton,et al.  Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. , 1996, Gynecologic oncology.

[16]  K. Clough,et al.  Facteurs pronostiques du cancer de l'endomètre: à propos de 206 cas traités à l'institut Curie. , 1995 .

[17]  Alice Chung,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[18]  E. Yordan,et al.  Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. , 1993, Gynecologic oncology.

[19]  A. Rademaker,et al.  Prognostic Factors Associated With Recurrence in Clinical Stage I Adenocarcinoma of the Endometrium , 1991, Obstetrics and gynecology.

[20]  Z. Holub,et al.  Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. , 2002, European journal of gynaecological oncology.

[21]  Z. Holub,et al.  Laparoscopically-assisted intraoperative lymphatic mapping in endometrial cancer: preliminary results. , 2001, European journal of gynaecological oncology.

[22]  H. Kerr,et al.  Observations on a “sentinel node” in cancer of the parotid , 1960, Cancer.